YU40643B - Process for obtaining a pharmaceutically acceptable, nonsolvatized anhydrous, crystalline form of sodium 7-(d-formyloxy-phenylacetamido)-3-(methyl-1h-tetrazole-5ylthiomethyl)-3-cephem-4-carboxylate - Google Patents

Process for obtaining a pharmaceutically acceptable, nonsolvatized anhydrous, crystalline form of sodium 7-(d-formyloxy-phenylacetamido)-3-(methyl-1h-tetrazole-5ylthiomethyl)-3-cephem-4-carboxylate

Info

Publication number
YU40643B
YU40643B YU792/76A YU79276A YU40643B YU 40643 B YU40643 B YU 40643B YU 792/76 A YU792/76 A YU 792/76A YU 79276 A YU79276 A YU 79276A YU 40643 B YU40643 B YU 40643B
Authority
YU
Yugoslavia
Prior art keywords
nonsolvatized
phenylacetamido
cephem
formyloxy
tetrazole
Prior art date
Application number
YU792/76A
Other languages
English (en)
Other versions
YU79276A (en
Inventor
Yang K Sh
K Sh Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU79276A publication Critical patent/YU79276A/xx
Publication of YU40643B publication Critical patent/YU40643B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
YU792/76A 1975-04-11 1976-03-26 Process for obtaining a pharmaceutically acceptable, nonsolvatized anhydrous, crystalline form of sodium 7-(d-formyloxy-phenylacetamido)-3-(methyl-1h-tetrazole-5ylthiomethyl)-3-cephem-4-carboxylate YU40643B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole

Publications (2)

Publication Number Publication Date
YU79276A YU79276A (en) 1982-10-31
YU40643B true YU40643B (en) 1986-04-30

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
YU792/76A YU40643B (en) 1975-04-11 1976-03-26 Process for obtaining a pharmaceutically acceptable, nonsolvatized anhydrous, crystalline form of sodium 7-(d-formyloxy-phenylacetamido)-3-(methyl-1h-tetrazole-5ylthiomethyl)-3-cephem-4-carboxylate

Country Status (31)

Country Link
US (1) US4006138A (xx)
JP (1) JPS51123812A (xx)
AR (1) AR210880A1 (xx)
AT (1) AT343806B (xx)
AU (1) AU500013B2 (xx)
BE (1) BE840179A (xx)
CA (1) CA1045114A (xx)
CH (1) CH621554A5 (xx)
CS (1) CS191970B2 (xx)
DD (1) DD125950A5 (xx)
DE (1) DE2614669C2 (xx)
DK (1) DK148022C (xx)
ES (1) ES446907A1 (xx)
FI (1) FI65069C (xx)
FR (1) FR2306698A1 (xx)
GB (1) GB1546898A (xx)
GR (1) GR59912B (xx)
HU (1) HU175592B (xx)
IL (1) IL49100A (xx)
LU (1) LU74740A1 (xx)
MX (1) MX3687E (xx)
NL (1) NL184258C (xx)
NO (1) NO151748C (xx)
OA (1) OA05290A (xx)
PL (1) PL104803B1 (xx)
PT (1) PT64917B (xx)
RO (1) RO68501A (xx)
SE (1) SE435290B (xx)
SU (1) SU668608A3 (xx)
YU (1) YU40643B (xx)
ZA (1) ZA761103B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (en) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
PT64917B (en) 1977-08-24
PL104803B1 (pl) 1979-09-29
ZA761103B (en) 1977-10-26
CA1045114A (en) 1978-12-26
FR2306698B1 (xx) 1979-10-05
NO151748C (no) 1985-06-05
CS191970B2 (en) 1979-07-31
JPS6110474B2 (xx) 1986-03-29
SU668608A3 (ru) 1979-06-15
AR210880A1 (es) 1977-09-30
DE2614669C2 (de) 1984-09-27
JPS51123812A (en) 1976-10-28
AU1143576A (en) 1977-09-01
NO761017L (xx) 1976-10-12
NL184258B (nl) 1989-01-02
YU79276A (en) 1982-10-31
IL49100A (en) 1979-03-12
FI65069B (fi) 1983-11-30
AT343806B (de) 1978-06-26
SE7602565L (sv) 1976-10-12
HU175592B (hu) 1980-09-28
IL49100A0 (en) 1976-04-30
DK148022B (da) 1985-02-04
GR59912B (en) 1978-03-20
ATA258476A (de) 1977-10-15
FI65069C (fi) 1984-03-12
PT64917A (en) 1976-04-01
FI760788A (xx) 1976-10-12
DD125950A5 (xx) 1977-06-01
NL7603660A (nl) 1976-10-13
FR2306698A1 (fr) 1976-11-05
DK148022C (da) 1985-07-22
BE840179A (fr) 1976-09-30
OA05290A (fr) 1981-02-28
US4006138A (en) 1977-02-01
GB1546898A (en) 1979-05-31
CH621554A5 (xx) 1981-02-13
SE435290B (sv) 1984-09-17
DK150676A (da) 1976-10-12
AU500013B2 (en) 1979-05-10
MX3687E (es) 1981-04-29
DE2614669A1 (de) 1976-10-21
NL184258C (nl) 1989-06-01
ES446907A1 (es) 1977-09-16
RO68501A (ro) 1981-04-30
NO151748B (no) 1985-02-18
LU74740A1 (xx) 1976-11-11

Similar Documents

Publication Publication Date Title
YU87378A (en) Process for preparing new cephem derivatives
YU40413B (en) Process for obtaining cephem compounds
DE2862468D1 (en) Process for the preparation of a (d-alpha-amino-(p-hydroxyphenyl)-acetamido) group containing cephalosporanic acid derivatives
AU3282378A (en) Process for producing 7-(substituted)amino-3-substituted thiomethyl cephalosporins
HU177906B (en) Process for preparing new prostane derivatives
YU311676A (en) Process for obtaining pharmacologically active compounds
YU40643B (en) Process for obtaining a pharmaceutically acceptable, nonsolvatized anhydrous, crystalline form of sodium 7-(d-formyloxy-phenylacetamido)-3-(methyl-1h-tetrazole-5ylthiomethyl)-3-cephem-4-carboxylate
JPS51123813A (en) Production of cephalosporin for nonnaural administration
HU178365B (en) Process for preparing prostaglandin analoques
YU300278A (en) Process for preparing cephalosporin compounds
HU175339B (hu) Sposob poluchenija farmacevticheski priemlemykh dibaznykh solejj beta-laktam-antibiotiki mm 17880
YU41875A (en) Process for preparing dry sodium 7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate
SU671732A3 (ru) Способ получени кристаллической безводной натриевой соли 7-( -2окси-2-фенилацетамидо)-3-(1-метил1н-тетразол-5-илтиометил)-3-цефем-4-карбоновой кислоты
GR61114B (en) Process for the production of pharmacologically active compounds
PT66661A (en) Process for preparing of 7-(alpha-2,3-dihydro-2-oxo-1h-benzimidazol-1-ylcarbonylamino)arylacetamido)cephalosporins
PT67732A (en) Process for preparing cephalosporin compounds
PT65932B (en) Process for the preparation of a crystalline modification of a sodium salt
EG13240A (en) Process for preparing of pharmacologically active compounds
YU11176A (en) Process for obtaining prostaglandin derivatives
GB1535293A (en) Method for producing cephalosporin compounds
YU204877A (en) Process for producing cephalosporin derivatives
YU73876A (en) Process for obtaining prostaglandin derivatives
YU308476A (en) Process for obtaining the crystalline anhydrous sodium 7-(d-2-hydroxy-2-phenylacetamido)-3-(methyl-1h-tetrazole-5-yl-thiomethyl)-3-cephem-4-carboxylate
IL49527A0 (en) Process for preparing prostaglandin derivatives
ZA76441B (en) Process for preparing 7-aminocephalosporanic acid derivatives